The medical community is excited by retatrutide, a innovative dual GIP and GLP-1 agonist that’s showing significant results in preliminary research. This medication works by mimicking natural hormones to impact appetite and click here boost feelings of satisfaction , ultimately contributing to substantial weight reduction . While still under eval